Airsculpt Technologies Amends 2025 Annual Report to Correct Overstated Non-GAAP Financials

summarizeSummary

Airsculpt Technologies filed an amended 10-K to correct errors in its non-GAAP financial measures for FY2025, revealing an overstatement of Adjusted EBITDA and Adjusted Net (Loss)/Income, further highlighting existing concerns about financial reporting accuracy.

check_boxKey Events

• Corrects Non-GAAP Financial Measures

  The company filed a 10-K/A to correct errors in the presentation of certain non-GAAP financial measures for the fiscal year ended December 31, 2025.

• Overstated Adjusted EBITDA and Net Loss

  The correction revealed an overstatement of Adjusted EBITDA by approximately $2.6 million and Adjusted Net (Loss)/Income by $0.1 million for FY2025.

• No Impact on GAAP or Audit Opinion

  The errors did not affect the company's consolidated financial statements prepared in accordance with U.S. GAAP or the related audit opinion.

• Reaffirms Existing Material Weakness

  The non-GAAP presentation errors do not reflect the identification of any additional material weaknesses in internal control over financial reporting beyond those previously disclosed in the original 10-K.

auto_awesomeAnalysis

Airsculpt Technologies filed an amended 10-K to correct errors in its non-GAAP financial measures for fiscal year 2025. While the corrections did not impact the company's GAAP financial statements or audit opinion, they revealed an overstatement of Adjusted EBITDA by $2.6 million and Adjusted Net (Loss)/Income by $0.1 million. This amendment, following the original 10-K's disclosure of a material weakness in internal controls, reinforces concerns about the accuracy of the company's financial reporting and internal control environment. Investors should note the ongoing challenges in financial reporting accuracy, even if GAAP results remain unaffected.